CompletedNCT04673851
This study exists to see whether a guided support group is workable and worth testing more broadly. Researchers are trying to understand whether a guided support group can make support easier to access outside standard clinic visits.
SchizophreniaOtherFrom 16 Years to 35 Years
- Countries
- United States
- Sponsor
- University of North Carolina, Chapel Hill
- Condition
- Schizophrenia
CompletedNCT04748679
This study exists to compare options and see whether cognitive behavioural therapy, a structured talking treatment, offers something meaningfully different. Researchers are trying to understand what cognitive behavioural therapy, a structured talking treatment, can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Vanderbilt University Medical Center
- Condition
- Schizophrenia
CompletedNCT01006551
This study exists to see whether a medication treatment is workable and worth testing more broadly. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 6 Years to 19 Years
- Countries
- United States
- Sponsor
- University of North Carolina, Chapel Hill
- Condition
- Schizophrenia
CompletedNCT04972227
This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- Tisento Therapeutics
- Condition
- Schizophrenia
TerminatedNCT03669640
This study exists to explore whether this type of care could improve care and understanding. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- Japan, Spain, Ukraine, United States
- Sponsor
- Hoffmann-La Roche
- Condition
- Schizophrenia
CompletedNCT03829280
This study exists to understand what helps a medication treatment work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Condition
- Schizophrenia
TerminatedNCT04210557
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
CompletedNCT02067975
This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
CompletedNCT05532683
This study exists to see whether psychoeducation, a guided learning and support program, is workable and worth testing more broadly. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve sleep, daily rhythms, and longer-term stability.
SchizophreniaOtherFrom 13 Years to 17 Years
- Countries
- United States
- Sponsor
- University of California, Los Angeles
- Condition
- Schizophrenia
CompletedNCT02969382
This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 40 Years
- Countries
- Hungary, Romania, Russian Federation, Ukraine, United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT02970929
This study exists to understand how the medication Safety holds up over time after the earliest research stage. Researchers are trying to understand how people respond to the medication Safety in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 40 Years
- Countries
- Hungary, Romania, Russian Federation, Ukraine, United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
RecruitingNCT06482554
This study exists to see whether this type of care can make care clearer and more responsive. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Louisiana State University Health Sciences Center Shreveport
- Condition
- Schizophrenia
CompletedNCT04072354
This study exists to understand whether a digital app or remote support tool is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
SchizophreniaOtherFrom 13 Years to 65 Years
- Countries
- Bulgaria, Colombia, Russian Federation, Serbia, Ukraine, United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT01940159
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT04865835
This study exists to see whether acceptance and commitment therapy, a talking treatment, can play a useful role in care. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT04369391
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT05463770
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT05402111
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT05848700
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT05542264
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT01994473
This study exists to better understand the safety of blood tests and biological markers and how manageable it feels in practice. Researchers are trying to understand how people respond to blood tests and biological markers in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT04092686
This study exists to understand whether a digital app or remote support tool is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Bulgaria, Croatia, Latvia, Russian Federation, Serbia, Ukraine, United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT04524403
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Corcept Therapeutics
- Condition
- Schizophrenia
TerminatedNCT03077347
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- United States
- Sponsor
- University of California, Davis
- Condition
- Schizophrenia
TerminatedNCT05643170
This study exists to understand how questionnaires and follow-up reports holds up over time after the earliest research stage. Researchers are trying to understand whether questionnaires and follow-up reports can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia